With pipelines diminishing and generics becoming more aggressive,
pharmaceutical companies must maximize their brands’ value and time on
the market. Strategic and well-orchestrated lifecycle management efforts
are crucial to maintaining a brand’s long-term health.
Cutting Edge Information’s report A Guidebook to Pharma Brand
Optimization analyzes the inner-workings of lifecycle management
strategy, development and implementation processes. This study provides
companies with the tools to improve their lifecycle management efforts
by exploring top pharmaceutical companies’ LCM structures, processes,
best practices, strategies and tactical approaches. The report makes its
case with metrics and techniques for launching effective
lifecycle management efforts.
- Structure and Funding – Learn how pharmaceutical companies
are establishing dedicated lifecycle management teams to spearhead
efforts. Benchmark functional involvement and funding support.
- LCM Processes, Challenges and Measurements – Examine top
companies’ lifecycle management LCM objectives and goals. Analyze the
processes companies take to launch comprehensive LCM strategies as
well as many common challenges they must overcome to be successful.
- Drug Time Periods – Explore the strategies that companies
should be considering at three major points in a drug’s lifecycle –
pre-launch, peak and mature time periods. Within each time period are
LCM tactic profiles that analyze the individual tactics in detail
including resources, timeframes and real-world case studies.
- Individual LCM Brand Profiles – Uncover the resource
support that individual brands receive for their lifecycle management
efforts annually during pre-launch, peak and mature time periods.
Use this study to win additional resource support for your lifecycle
management efforts. Examine the brand profiles and case studies to learn
from real-world company examples.
|
More Cutting Edge
Information Reports: |
|
 |
 |
 |